Dr. Barış Erdoğan
CEO
Clinerion Ltd

Barış Erdoğan studied computer engineering and holds an M.Sc. and Ph.D. in educational technology. He practiced data mining techniques in various sectors including healthcare. He lectures on the topics of software development, database management, medical informatics, and project management. His expertise and experience include the management of innovative Medical Informatics projects and implementation of end-to-end Healthcare IT enterprise information systems, both in the public and private sectors

Shefali Agarwal, MD, MPH, MBA
Chief Medical and Development Officer and trained medical oncologist
Epizyme

Shefali Agarwal, M.D., MPH, MBA, is Epizyme’s Chief Medical & Development Officer and a trained medical oncologist. Dr. Agarwal served as Chief Medical Officer at SQZ Biotech, where she built and led clinical development, including clinical research operations and regulatory functions. Shefali also held leadership positions at Curis and Tesaro.  She also serves on the on the Board of Directors for FATE, Gritstone Bio and ITB-Med and Onexo where she is the Chair.

Dr. Agarwal was a recipient of the 17th Annual 20 Outstanding Women of the Year award for the year 2019 from INDIA New England News, and invited panelist speaker of Chief Medical Officer Summit 360˚.

Dr. Michael G. Kauffman, M.D., PhD
Chief Executive Officer and Co-Founder
Karyopharm Therapeutics Inc.

Dr. Kauffman co-founded Karyopharm Therapeutics with Dr. Sharon Shacham in 2008 and served as the Chief Executive Officer from January 2011 to April 2021, as Chief Medical Officer from December 2012 to July 2019, and as a director since 2008. He is currently Senior Clinical Advisor and helps guide clinical development for Karyopharm’s robust pipeline, with an increasing focus on solid tumor indications.

Dr. Kauffman received a Bachelor of Arts in Biochemistry from Amherst College, a Doctor of Medicine and Doctor of Philosophy from Johns Hopkins Medical School, and trained in internal medicine and rheumatology at Beth Israel (now Beth Israel Deaconness Medical Center) and Massachusetts General Hospitals. He is board certified in internal medicine.

Mark Mogul
Head of Medical Affairs
Servier Pharmaceuticals

Mark Mogul, MD, serves as the Head of Medical Affairs at Servier Pharmaceuticals. Mark earned his medical degree from the SUNY Health Science Center at Syracuse, completed a fellowship in Pediatric Hematology-Oncology at Stanford University, and a Bone Marrow Transplant Fellowship at the Fred Hutchinson Center in Seattle, Washington. Prior to joining Servier, Mark worked as a Pediatric Hematologist-Oncologist for 27 years, and in 2018, was recognized as one of Tampa Magazine’s “Best Physicians.”

Dr. Iain Webb, MD FRCPC
Head of US Medical Affairs
Bayer Oncology

Iain is Vice President and Head, US Medical Affairs, Oncology at Bayer.  Prior to joining Bayer, Iain held various Medical Affairs and Clinical Development roles at Millennium Pharmaceuticals, Takeda Oncology and Pfizer.  Previously, he was an Attending Physician at the Dana-Farber Cancer Institute.  Iain obtained his M.D. degree from McGill University in Montreal, Canada, then completed internal medicine residency and hematology fellowship at McGill University, and hematology/oncology fellowship at Beth Israel Hospital Boston/Dana-Farber Cancer Institute.